Jerath Varun, Vallur Srujan, Singh S K, Gupta Vikas, Chugh Rajeev, Kumari Abha, Kumar Sanjay
Army Hospital (Research and Referral) AH (R&R), New Delhi, 110010 India.
Air Force Central Medical Establishment (AFCME), Subroto Park, New Delhi, India.
Indian J Otolaryngol Head Neck Surg. 2025 Jul;77(7):2487-2493. doi: 10.1007/s12070-025-05532-2. Epub 2025 May 22.
Spontaneous cerebrospinal fluid (CSF) rhinorrhoea, often linked to benign intracranial hypertension (BIH), arises from skull base defects and carries a risk of serious complications such as meningitis. While acetazolamide can temporarily reduce intracranial pressure, recurrence remains problematic. This prospective study aims to assess the relationships between body mass index (BMI), defect size, disc edema severity, and recurrence duration, and to compare outcomes of conservative versus surgical management. A prospective observational study was conducted on 30 adults with spontaneous CSF rhinorrhoea from November 2021 to October 2023. Initial treatment involved oral acetazolamide (250 mg thrice daily); patients with recurrence underwent endoscopic endonasal repair. All surgical patients received two doses of the pneumococcal vaccine, 8 weeks apart. Associations between BMI, defect size, disc edema, and recurrence duration were analysed using Pearson's correlation coefficient. Mean BMI was 26.63, and mean defect size was 7.37 mm. Moderate positive correlations were observed between BMI and recurrence duration (r = 0.45, = 0.018), and between disc edema and recurrence duration (r = 0.52, = 0.004). A weak yet significant correlation was found between defect size and recurrence duration (r = 0.38, = 0.032). Conservative management failed in all cases; recurrence occurred in 100% of patients, necessitating surgical repair, which achieved a high success rate with minimal postoperative recurrence. Acetazolamide offers temporary relief but fails to prevent recurrence. Early surgical intervention is recommended in spontaneous CSF rhinorrhoea to ensure better long-term outcomes and reduce the risk of complications, particularly in patients with elevated BMI or advanced papilledema.
自发性脑脊液鼻漏常与良性颅内高压相关,源于颅底缺损,并有发生脑膜炎等严重并发症的风险。虽然乙酰唑胺可暂时降低颅内压,但复发问题依然存在。本前瞻性研究旨在评估体重指数(BMI)、缺损大小、视盘水肿严重程度与复发持续时间之间的关系,并比较保守治疗与手术治疗的效果。2021年11月至2023年10月,对30例自发性脑脊液鼻漏的成人患者进行了一项前瞻性观察研究。初始治疗为口服乙酰唑胺(每日三次,每次250毫克);复发患者接受内镜下鼻内修复术。所有手术患者均接受两剂肺炎球菌疫苗,间隔8周。使用Pearson相关系数分析BMI、缺损大小、视盘水肿与复发持续时间之间的关联。平均BMI为26.63,平均缺损大小为7.37毫米。观察到BMI与复发持续时间之间存在中度正相关(r = 0.45,P = 0.018),视盘水肿与复发持续时间之间也存在中度正相关(r = 0.52,P = 0.004)。缺损大小与复发持续时间之间存在弱但显著的相关性(r = 0.38,P = 0.032)。所有病例的保守治疗均失败;100%的患者复发,需要进行手术修复,手术成功率高,术后复发率低。乙酰唑胺可提供暂时缓解,但无法预防复发。对于自发性脑脊液鼻漏,建议早期手术干预,以确保更好的长期效果并降低并发症风险,特别是对于BMI升高或有晚期视乳头水肿的患者。